<html xmlns="http://www.w3.org/1999/xhtml"><head>
        <meta http-equiv="Content-Type" content="text/html; charset=utf-8">
        <meta name="viewport" content="width=device-width, height=device-height, initial-scale=0.5, minimum-scale=0.5, user-scalable=yes, maximum-scale=2.0, target-densitydpi=device-dpi" />
				<meta name="robots" content="all"/>
        <meta name="description" content="description">
        <meta name="keywords" content="">
        <title>Page 196 - MIMS April 2020 E4</title>
<style type="text/css">
<!--
body {
	margin-left: 0px;
	margin-top: 0px;
	margin-right: 0px;
	margin-bottom: 0px;
}
  
#container {margin:50px auto;padding:0px;width:910px;}
#left-button{ width:90px; height:100%;float:left }
#middle{ width:730px; margin:0px; float: left;}
#right-button{ width:90px; float:left;}
html, body, div, ul, li, dl, dt, dd, h1, h2, h3, h4, h5, h6, form, input, dd,select, button, textarea, iframe, table, th, td { margin: 0; padding: 0; }
img { border: 0 none; displayblock}
span,ul,li,image{ padding:0px; margin:0px; list-style:none;}
#top-title{ width:714px; margin-bottom:10px; float:left; padding:0px 8px}
#top-title2{ width:320px;  float:right;}
#content{ width: 730px; float:left;float:left;word-wrap: break-word;}
#content-top{ width:730px; background-image:url(images/top_bg.jpg); height:56px; background-repeat:no-repeat; float:left;}
#content-top1{ width:70%; padding:16px 0px 0px 30px; font-family:Arial, Helvetica, sans-serif; font-size:24px; color:#636363;float:left;}
#content-top2{ width:60px; float:right; padding:25px 30px 0px 0px;font-family:Arial, Helvetica, sans-serif; font-size:11px; color:#2f2f2f; font-weight:bold; text-align:right}
#content-middle{ width:730px; background-image:url(images/middle_bg.jpg); background-repeat:repeat-y;float:left;}
#content-middle1{ width:475px; padding:25px 0px 25px 35px; font-family:Arial, Helvetica, sans-serif; font-size:12px; color:#636363; line-height:150%;float:left;}
#content-middle2{  padding:7px; float:right; margin:25px 35px 0px 0px; border:solid 1px #c8c8c9; background-color:#FFF; text-align:center}
#content-bottom{ width:730px; background-image:url(images/bottom_bg.jpg); background-repeat:no-repeat; height:58px;float:left;}
#content-bottom2{ width:110px; height:42px; margin:0px auto; padding-top:4px;}
#input{ width:58px; height:20px; background-color:#FFF; border:solid 1px #dfdfe0; color:#636363; text-align:center; font-size:11px;}
.font1{ font-family:Arial, Helvetica, sans-serif; font-size:10px; color:#2f2f2f;}
.font1 a:link{
	text-decoration: none;
    color:#2f2f2f;

}
.font1 a:visited{
	text-decoration: none;
    color:#2f2f2f;
	
}
.font1 a:hover{
	color: #2f2f2f;
	text-decoration: underline;

}



.text-container {
padding: 20px;
color: #333;
margin-top: 24px;
line-height: 22px;
border-top-left-radius: 3px;
border-top-right-radius: 3px;
}

.use-as-video {
float: right;
padding-left: 20px;
}
.cc-float-fix:before, .cc-float-fix:after {
content: "";
line-height: 0;
height: 0;
width: 0;
display: block;
visibility: hidden;
}
.use-as-video-img {
cursor: pointer;
position: relative;
width: 320px;
height: 180px;
}
.use-as-video-title {
font-size: 15px;
font-weight: bold;
color: #000000;
padding-bottom: 5px;
}
-->
</style>
<script type="text/javascript">
<!--
function MM_preloadImages() { //v3.0
  var d=document; if(d.images){ if(!d.MM_p) d.MM_p=new Array();
    var i,j=d.MM_p.length,a=MM_preloadImages.arguments; for(i=0; i<a.length; i++)
    if (a[i].indexOf("#")!=0){ d.MM_p[j]=new Image; d.MM_p[j++].src=a[i];}}
}

function MM_swapImgRestore() { //v3.0
  var i,x,a=document.MM_sr; for(i=0;a&&i<a.length&&(x=a[i])&&x.oSrc;i++) x.src=x.oSrc;
}

function MM_findObj(n, d) { //v4.01
  var p,i,x;  if(!d) d=document; if((p=n.indexOf("?"))>0&&parent.frames.length) {
    d=parent.frames[n.substring(p+1)].document; n=n.substring(0,p);}
  if(!(x=d[n])&&d.all) x=d.all[n]; for (i=0;!x&&i<d.forms.length;i++) x=d.forms[i][n];
  for(i=0;!x&&d.layers&&i<d.layers.length;i++) x=MM_findObj(n,d.layers[i].document);
  if(!x && d.getElementById) x=d.getElementById(n); return x;
}

function MM_swapImage() { //v3.0
  var i,j=0,x,a=MM_swapImage.arguments; document.MM_sr=new Array; for(i=0;i<(a.length-2);i+=3)
   if ((x=MM_findObj(a[i]))!=null){document.MM_sr[j++]=x; if(!x.oSrc) x.oSrc=x.src; x.src=a[i+2];}
}
//-->
</script>
</head>

<body onload="MM_preloadImages('images/next2.png','images/previous2.png')">
<div id="container">
<div id="left-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page195.html"><img src="images/previous_big.png" width="90" height="80" /></a></p>
</div>
<div id="middle">
  <div id="top-title"><span class="font1">Basic HTML Version</span>
    <div id="top-title2">
      <table width="100%" border="0" align="right" cellpadding="0" cellspacing="0">
        <tr>
        	<td width="66%"> </td>
          <td width="35%" style="display:none" align="right"><img src="images/content.png" width="19" height="16" /></td>
          <td width="31%" style="display:none" class="font1"><a href="">Table of Contents</a></td>
          <td width="6%"><img src="images/view.png" width="19" height="16" /></td>
          <td width="28%" class="font1"><a href="../../MIMS April 2020 E4.html#p=196">View Full Version</a></td>
        </tr>
      </table>
    </div>
  </div>
  <div id="content">
     <div id="content-top">
        <div id="content-top1">Page 196 - MIMS April 2020 E4</div>
        <div id="content-top2">P. 196</div>
     </div>
     <div id="content-middle">
     	
     	  <div class="text-container">
    <div class="use-as-video cc-float-fix">
      <a style="text-decoration: none;" href="../../MIMS April 2020 E4.html#p=196"><img src="../thumb/196.jpg" /></a>
    </div>

    <p class="use-as-video-title"></p>
    <pre style="white-space:pre-line"><code>162 / 2020-04                                                      Respiratory System - 10.2.4 / 10.3
   SYMBICORD, AstraZeneca       narr.angle glauc., urin. outflow obstruct., not stud.in sev.ren.impairm./  Indications: Adjunct.therapy in resp.tract. disords. charact.by ex-
   Budesonide 80(160) µg, formoterol fumarate dihydrate 4,5 µg/dose.  end stage ren.dis., CV disords.esp.coron.artery dis./ac. MI/ card.dys-  cess muc.in absen.of infect.
   Indications: Asthma in adolesc.& adults where combinat. inhal.   rhythm./hypertens., convuls.disords., hyperthyroid./diab.mellit./pts.  (S2) SYRUP. S/10.2.2/146.
   corticoster.& long act.ß-agon. ther.appropriate.  unusual.respons.to beta-2-adrenerg.agon., signific.CV effs.poss.req.   708151-019: 250 mg/5 ml, 200 ml, R27,08
   160 :4,5 µg strength also mod.to sev.COPD with freq. sympt.& hist.  discont., card.dysrhythm.risk with hypokalaem. poss. potent.by hy-  708151-027: 250 mg/5 ml, 2,5 L, R338,62
   of exacerbat.                pox.& concom.treatm., close monit. of plasma gluc in diabet., lact.  Dosage: Adults: 10-15 ml. 3x dly. Childr: 2-5 yrs: 1,25-2,5 ml. 4x
   (S4) TURBUHAL. 35/21.5.1/0404, 0405.  intol., safety in pregn. & lactat.not est., poss.labour inhibit.,no data   dly. 6-12 yrs: 5 ml 3x dly.
   705986-001: 80/4,5 µg/inhal., 120 dos., R409,43  avail.in sev.hepat.impairm.  Contraindications: Act.pept.ulc., childr.und.2 yrs. not recomm.
   700172-001: 160/4,5 µg/inhal., 60 dos., R150,00  Interactions: Concom.beta-adrenerg.blocks.not advis.(incl.eye   Side effects: Naus., diarrh., headache.
   700173-001: 160/4,5 µg/inhal., 120 dos., R300,00  drops), concom.MAOI/TCA’s/meds. known to prolong QT-interv.as   Special precautions: Gastr./duod.ulc.hist.
   Dosage: Indiv.accord.to sev. When contr.achiev. titrat. to low.dos.at   eff.on QT interv. poss.potent., incr.ventric.dysrhythm.risk with meds.
   which sympt.contr.is maint.   known to prolong QT interv., incr.S/E with other sympathomimets., hy-  BISOLVON 0,2%, Sanofi-Aventis [P/S]
                                                          +
   Two treatm.approach for asthma:  pokalaem.eff.poss. potent.by methylxanthin.deriv./ster./non K -spar.   Bromhexine HCl.
   Maint.ther: Adults 18 yrs.& old: 1-2 inhalat.of either strength   diuret., syst.clear.influenc.by modulat.of both P-gp and CYP3A4 activ.,   Sugar Free
   2xdly. Max: 4 inhalat.2xdly.as maint. /tempor.dur.worsen. Ado-  concom.inhal.anticholinerg. contain. med.not recomm., cimetid.incr.  Indications: Cough assoc.with non-purul.excess. sputum product.
   lesc.12-17 yrs: 1-2 inhalat.of either strength 2xdly. Temp.incr.to   AUC and decr.ren.clear.of glycopyrron.  (S2) SOL, G642. 10 mg/5 ml.
   max. 4 inhalat.2xdly.dur. worsen.  See also MDR page 583.  710040-008:, 50 ml, R99,87
   Maint.& reliev.ther: Adults 18 yrs.& old: Maint (80:4,5): 2 inha-  Dosage: Oral: Adults & childr.over 10 yrs:
   lat./day given as 1 inhalat. in morn. & even. OR 2 inhalat.in either   VANNAIR, AstraZeneca [P/S]  5-10 ml 3xdly. Childr.und.10 yrs: 2,5-5 ml 3xdly.
   morn./ even. Maint (160:4,5): 2 inhalat./day given as 1 inhalat.in   Budesonide 80(160) µg, formoterol fumarate dihydrate 4,5(4,5) µg/dose.  Inhal.from respirator: May be dil.1:1 with physiolog. NaCl.
                                Indications: Asthma in adults & childr.6 yrs.& old. where cont.use
   morn. & even. OR 2 inhalat.in either morn./even. Some pts.may   Admin.2xdly. Warm.sol.prev. poss.init.irrit.cough. If used in pres.of
   req.2 inhalat.2xdly. Take 1 addit.inhalat.as need.in respons.to sympts.   of combin.inhal. corticoster.& long act.ß-agon.ther.appropr., mod.to   bronchosp. admin.brochodilat.first.
                                sev.COPD treatm.with freq. sympt.& hist.of exacerbat.
   If sympts.persist.an addit.dos.may be taken aft.a few mins. Max.6 in-  Adults: 4 ml. Childr.over 12 yrs: 2 ml. 6-12 yrs: 1 ml. 2-6 yrs:
   halat.on any sngl. occas. Tot.dly.dos.of more than 8 inhalat.not norm.   (S4) INHALER. A39/21.5.1/0506, 0507  10 drps. Und. 2 yrs: 5 drps.
                                720218-001: 80/4,5 µg, 120 actuat., R207,00
   reqd.however tot.dly.dos.of upto 12 inhalat. maybe used tempor.  Side effects: GI disturbs., headache, dizzin., weat., trans.rise in
   Adolesc.12-17 yrs: Maint (80:4,5): 2 inhalat./ day given as 1 inhalat.  720219-001: 160/4,5 µg, 120 actuat., R300,00  ser.aminotransfrase, skin & allerg.reacts., bronchosp., anaphylax.
                                Dosage: Indiv.accord.to dis.sev. When contr. achiev. titrat. to low.
   in morn.& even.OR 2 inhalat. in either morn./even. Maint (160:4,5): 2   dos.at which effect.sympt. contr.is maint.  Special precautions: Pept.ulc., asthmat.pt., sev.hepat./ren.im-
                                                              pairm., incr.flow of secret., safety in pregn.& lactat.not est.
   inhalat./day given as 1 inhalat.in morn.& even. OR 2 inhalat.in either
   morn./even. Some pts.may req.2 inhalat.2xdly. Take 1 addit.inhalat.  Asthma: Adults 18 yrs.& old: Vannair 80:4,5 or 160:4,5: 2 inhal.2x/  BRONCHETTE, (Aspen Pharmacare) Pharmacare [P/S]
                                day. Max. 4 inhal.2x/day may be requir.as maint.dos.or tempor.dur.
   as need. in respons.to sympts. If sympts.persist.an addit. dos.may be   Carbocysteine.
   taken aft.a few mins. Max.6 inhalat. on any sngl.occas. Tot.dly.dos.  asthma worsen. Adolesc.12-17 yrs: 2 inhal.2x/day. May tempor.be   Indications: Adjunct.in respir.tract disords. charact. excess.visc.
                                incr.to max. 4 inhal.2x/day dur.asthma worsen.
   of more than 8 inhalat. not norm.reqd.however tot.dly.dos.of upto 12   mucus in absen.of infect.
   inhalat.may be used tempor.  Childr: Vannair 80:4,5: Childr.6-11 yrs: 2 inhal. 2x/day with 4 in-  (S2) SYRUP, [P/S] L/10.1/320.
                                hal.as max.dly.dos.
   COPD (160:4,5): Adults: 2 inhal.2xdly. Max.4 inhalat./ day.  710520-018: 250 mg/5 ml, 200 ml, R24,05
   (S4) TURBUHAL. 320/9 µg/inhal. 38/21.5.1/0187  COPD: Vannair 160:4,5: Adults 18 yrs & old: 2 inhal. 2x/day. Max.  Dosage: Adults: 10-15 ml 3xdly. Childr. 5-12 yrs: 5 ml 3xdly. 2-5
                                dly dos.4 inhal.
   Budesonide 320 µg, formoterol fumarate dihydrate 9 µg/dose.  Contraindications: Init.ther.dur sev.exacerbat., safety in pregn.&   yrs: 2,5 ml 2-4xdly.
   Indications: Adult & adolesc.asthma where combinat. high dos.   lactat.not est., no data avail.in hepat./ren.impairm.  Contra-indications: Act.pept.ulc., safety in pregn. not est.
   inhal.corticoster.& long act. ß-agon.ther. appropriate, reg.treatm.of   Side effects: Tremor, palpitat., candida infects. in oropharynx., head-  Side-effects: Naus., diarrh., headache, GI bleed., skin rash.
   mod.to sev.COPD with freq. sympt. & hist.of exacerbat.  ache, throat irrit., cough., hoarsen., tachycard., naus., musc.cramps,   Special precautions: Gastr./duod.ulc.hist
   705984-001: 320/9 µg/inhal., 60 dos., R300,00  dizzin., psych. disords., card.arrhythm.assoc.with ß 2-agon., hypersens.
   Dosage: Indiv.accord.to sev.titrat.to low.effect. dos.for sympt.contr.   reacts.incl.skin/ anaphylact. reacts./ angioed., bronchosp., skin bruis.,   CO-FLEM, (Unicorn) Pharmacare [P/S]
   Not for ac.asthma attack.    ang. pect., S&S of system.glucocortic.effs.incl. adren. hypofunct., hy-  Carbocisteine
   Asthma: Adults 18 yrs.& old: 1 inhalat.2xdly. Max:2 inhalat.2xdly.  +  Indications: Adjunct.in resp.tract disords. charact. by excess.visc.
   as maint./dur.worsen.asthma  perglycaem., low.ser.K  with high dos.  mucous in absenc.of infect.
                                Special precautions: Excret.in breast milk, cont. ther.even if asymp-
   Adults & adolesc.12 –17 yrs: 1 inhalat.2xdly. Incr. tempor.to max.2   tomat., taper dos.when long-term treatm.is discont., sudd.& progress.   (S2) SYRUP, V/10.2.2/29. 250 mg/5 ml
   inhalat.2xdly.dur.worsen. asthma  deteriorat.in contr.of asthma/COPD potent.life threat., have separat.  779814-002: 200 ml, R23,01
   COPD: Adults 18 yrs.& old: 1 inhal.2xdly. Max. dly. dos: 2 inhalat.  rapid act.bronchodil.for rescue treatm., re-assess ther.if condit.wors-  Dosage: Adults: 10-15 ml 3xdly. Childr. 5-12 yrs: 5 ml 3xdly. 2-5
   Contraindications: Safety & effic.in.childr.und. 12 yrs. not est., init.  en., monit.childr./adolesc.growth, transf.from oral to inhal.glucocor-  yrs: 2,5 ml 2-4xdly.accord.to age.
   ther.dur sev.exacerbat., safety in pregn.& lactat.not est., no data avail.  ticoster., pts.requir.prolong. treatm. at high dos., sev.CV disords./liv.  Contraindications: Act.pept.ulc., safety in pregn. not est.
   in hepat./ ren.impairm., inhal.lact.intol.  dis., diab. mellit., untreat.hypokalaem., thyrotoxicos., consult dr.if   Side-effects: Naus., diarrh., headache, GI bleed., skin rash, palpi-
   Side effects: Trem., palpitat., headache, candida infects.of orophar-  treatm.becom.ineffect./prescrib.dos. exceed., surg./infect./condits.  tat., dizzin., heartburn.
   ynx., throat irrit., cough., hoarsen., tachycard., naus., musc. cramps,   assoc.with sev. electr. loss/ stress, consid.addit.system. corticoster.   Special precautions: Gastr./duod.ulc.hist.
   dizzin., psych.disords., card.arrhythm. assoc. with ß2-agon., hypers-  dur.stress per./elect.surg., longt. ketoconazole treatm.  LESSMUSEC, Brunel [P/S]
   ens.reacts.incl. exanthema/urticar./ prurit.& angioed., bronchosp.,   Drug interactions: CYP3A4 inhibit.eg. ketoconazole may incr.syst.  Carbocisteine
   skin bruis., ang. pect., S&S of system. glucocortic.effs.incl.adren.   expos.to budesonide, concom.ß-adrenerg.block.incl.eyedrops may in-  Indications: Adjunct.in resp.tract disords.charact. by excess.visc.
                  +
   hypofunct., hyperglycaem., low.ser.K  with high dos.  hib./ weak.eff.of formoterol, quinidine/ disopyramide/ procainamide/  muc.in absenc.of infect.
   Special precautions: Corticoster.teratogen.in anim., sev.CV disor-  phenothiazin./ antihistam./ MAOI’s/TCA’s can prolong QTc interv. &   (S2) CAPS, T/10.2.2/227. 375 mg.
   ds., diab.mellit., untreat hypokalaem., thyrotoxicos., longt.ketocona-  incr.ventr.dysrhythm.risk.  783633-130, 30, R35,93
   zole treatm., have separat.rapid act.bronchodil.for rescue treatm.,   783633-122, 1 000, R1 197,37
   re-assess ther.if incr.inhalat. reqd. for sympt.contr.without improv.  Dosage: 2 caps 3xdly. Once satisfact.respons. reduc. to 1 cap 4xdly.
   asthma contr. within 3 days, sev.liv.cirrhos., continuat.of ther. even if   Contraindications: Act.pept.ulc.
   asymptomat., re-assess ther.if condit. worsen., monit.childr./adolesc.  10.3  Mucolytics  Side effects: Naus., diarrh., headache, skin rash, palpits.
   growth, transf. from oral to inhal.glucocorticoster., sudd. & progress.   Special precautions: Gastr./duod.ulc.
   deteriorat.in contr.of asthma/COPD potent.life threaten., pts.requir.  ACC 200, Sandoz [P/S]
   prolong.treatm.at high dos., surg./infect./condits.assoc.with sev. elec-  N-acetylcysteine.  MUCATAK, Actor Pharma [P/S]
   trol. loss/sev.stress,consid.addit.system. corticoster. dur. stress/elect.  Indications: Mucolyt.of non-infect.secret.in cyst.fibros.& resp.  Acetylcysteine.
   surg., taper dos. when long-term treatm.is discont.  condits.  Indications: Mucolyt.in resp.condits.& reduc. viscos. of non-infect.
   Drug interactions: CYP3A4 inhibit.eg ketoconazole/ macrolides/  (S1) EFFERVESC.TABS. 29/10.2.2/0753.  secret in cyst.fibros.
   HIV protease inhibits. may incr.syst.expos.to budesonide, concom.ß-  824291-018: 200 mg, 25, R85,93  (S1) EFFERVESC.TABS. 44/10.1/0927
   adrenerg.block.incl.eyedrops may inhibit./weak. eff.of formoterol,   824291-019: 200 mg, 40, R137,51  718049-001: 200 mg, 25, R75,33
   quinidine/disopyramide/ procainamide/phenothiazin./antihistamin.  Dosage: Dissol.in water bef.admin.  Dosage: Dissolve tabs.bef.admin.
   eg. terfenadine, MAOI’s & TCA’s can prolong QTc interv. & incr.risk   Mucolyt: Childr.2-5 yrs: Half a tab.2-3xdly. 200 mg dly. 6-14 yrs: 1   Mucolyt: Childr.2-6 yrs: ½ 200 mg 2-3xdly. 6-14 yrs: 200 mg 2xdly.
   of ventr.arrhythm.           tab. 2xdly. Adults & adolesc.from 14 yrs: 1 tab.2-3xdly.  Adults: 200 mg 2-3xdly.
   ULTIBRO BREEZHALER, Novartis &  Contraindications: Pregn., safety in lactat.not est., childr.und.2 yrs.   Contraindications: Safety in pregn.& lactat.not est., no exper.
                                                              in childr.und.2 yrs.
   Indacaterol mal.110 µg, glycopyrronium 50 µg  Side effects: Tinnit., dyspn., bronchosp., GI disturbs., headache, fev.,   Side effects: Headache, fev., chills, tinnit., allerg./ anaphylact.
   Indications: Chron.obstruct. pulm.dis.when pts still symptomat.de-  allerg.reacts.incl. anaphylax.  reacts., dyspn., rhinorrh., bronchosp., GI disturbs., flush., syncope,
   spite long act.ß-adrenerg. agons./ long act.muscarin.antagon.treatm.  Special precautions: Asthma, pept.ulcerat., 2 hr.interv.betw.admin.  sweat., arthralg., blurr.vis., liv.funct.disturbs., acidos., convuls., card./
   (S3) DRY POWD.INHAL.CAPS, 47/10.2.1/1183  of tetracycl.HCl & other oral antibiot.  resp.arrest, haemoptys.
   723867-001: 30, R484,55      AMUCO 200, (Austell) Camox [P/S]  Special precautions: Asthma, elderly pts.with resp.insuff., phe-
   Dosage: Not for use in pts.und.18 yrs. Do not swallow cap. Do not   N-acetylcysteine.  nylketonur.as cont. aspartame, gastr.ulc.hist., concom.cough sup-
   take more than 1 dos/day. Only remove from package.immed.bef.use  Indications: Mucolyt.of non-infect.secret.in cyst. fibros.& resp.  press., rec. gastro-duod.ulcerat.
   Gen.target populat: Recomm.dos: once dly. inhalat of cap.contents   condits.
   using the inhal.at the same time each day.  (S2) EFFERVESC.TABS. 43/10.2.2/0510.  MUCOSOLV, (Cipla Medpro) Mirren [P/S]
   Side effects: URTI, nasopharyngit.,UTI, sinusit., rhinit., hypersens.,   716267-001: 200 mg, 2x10, R63,95  Carbocisteine
   hyperglycaem., diab.mellit., insomn., dizzin., headache, paraesthes.,   Dosage: Dissolve tabs.bef.admin.  Indications: Adjunct.in resp.tract disords. charact. by excess.visc.
   glauc., ischaem.heart dis., atrial.fibrillat., tachycard., palpitat., cough,   Childr.und. 2 yrs: 200 mg 1xdly. 2-6 yrs: 200 mg 2xdly. Adults:   muc.in absenc.of infect.
   oropharyng.pain incl.throat irrit., epistax., paradoxic.bronchosp., gas-  200 mg 3xdly.  (S2) CAPS, W/10.1/57. 375 mg.
   troenterit., dyspeps., dent.car., prurit., rash, musculoskelet. pain, musc.  Contra-indications: Safety in pregn.& lactat.not est.  723074-001: 30, R28,72
   spasm, extremity pain, myalg., bladd. obstruct.& urin.retent., pyrex.,   Side-effects: Headache, N&V, stomatit., bronchosp., rhinorrh., tin-  Dosage: Adults: 2 caps 3xdly. Reduc.to 1 cap 4xdly.once satis-
   chest pain, periph. oed., fatig., angioed., dysphon., dry mouth, asthen.,   nit., allerg. dermatit., urticar., anaphylax., chills, fev., poss.disrupt.   fact.respons.obt.
   sinus congest., hypoaesthes.  gastr.mucos.barrier.         Contraindications: Act.pept.ulc.
   Warnings and special precautions: Do not admin concom.with   Special precautions: Asthma, pept.ulc.hist.  Side effects: Naus., diarrh., gastric discomf., GI bleed., skin rash,
   prods.contain.other long-act. beta2-adrenerg.agonists/ long act.  headache.
   muscarin. antagon., asthma, not for use in ac.bronchosp., discont.  BETAPHLEM, Ranbaxy [P/S]  Warnings and special precautions: Pept./ duod. ulc., safety in
   immed.in pres.of hypersens.signs/in event of paradoxic. bronchosp.,   Carbocisteine.  pregn.& lactat.not est.</code></pre>
     	</div>
    
     </div>
     <div id="content-bottom">
       <div id="content-bottom2">
         <table width="110" border="0" cellspacing="0" cellpadding="0">
           <tr>
             <td width="22%" height="44"><a href="page195.html"><img src="images/previous.png" width="26" height="19" id="Image2" onmouseover="MM_swapImage('Image2','','images/previous2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
             <td width="43%">
             	&nbsp;&nbsp;&nbsp;<a href="page191.html">191</a>&nbsp;&nbsp;&nbsp;<a href="page192.html">192</a>&nbsp;&nbsp;&nbsp;<a href="page193.html">193</a>&nbsp;&nbsp;&nbsp;<a href="page194.html">194</a>&nbsp;&nbsp;&nbsp;<a href="page195.html">195</a>&nbsp;&nbsp;&nbsp;<a href="page196.html">196</a>&nbsp;&nbsp;&nbsp;<a href="page197.html">197</a>&nbsp;&nbsp;&nbsp;<a href="page198.html">198</a>&nbsp;&nbsp;&nbsp;<a href="page199.html">199</a>&nbsp;&nbsp;&nbsp;<a href="page200.html">200</a>&nbsp;&nbsp;&nbsp;<a href="page201.html">201</a>
             </td>
             <td width="35%"><a href="page197.html"><img src="images/next.png" width="26" height="19" id="Image1" onmouseover="MM_swapImage('Image1','','images/next2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
           </tr>
         </table>
       </div>
     </div>
  </div>
</div>
<div id="right-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page197.html"><img src="images/next_big.png" width="90" height="80" /></a></p>
</div>


</div>

</body>
</html>
